Dr. Christopher Tallman is a board-eligible urologist who practices general urology with a special focus on minimally invasive surgical management of benign and malignant prostate disease. He earned is Master of Science in Miami, FL and his Doctor of Medicine from Medical University of the Americas in Nevis, West Indies. He went on to complete his surgical internship at the University of Miami and pursued a research fellowship under Dr. Mani Menon at Henry Ford Hospital in Detroit, MI. Dr. Tallman completed his residency as the first resident at the esteemed Houston Methodist Hospital.

Dr. Tallman is largely focused on advancing patient outcomes with the use of Aquablation for the management of benign prostate disease (BPH) and was the first in South Florida to treat prostate cancer utilizing Aquablation in a global multicenter, prospective, randomized FDA clinical trial. He provides cutting edge therapies to men with these conditions at Delray Medical Center.